TY - JOUR
T1 - Self-reported sleep problems in active-duty US Army personnel receiving posttraumatic stress disorder treatment in group or individual formats
T2 - secondary analysis of a randomized clinical trial
AU - STRONG STAR Consortium
AU - Pruiksma, Kristi E.
AU - Taylor, Daniel J.
AU - Wachen, Jennifer Schuster
AU - Straud, Casey L.
AU - Hale, Willie J.
AU - Mintz, Jim
AU - Young-McCaughan, Stacey
AU - Peterson, Alan L.
AU - Yarvis, Jeffrey S.
AU - Borah, Elisa V.
AU - Dondanville, Katherine A.
AU - Litz, Brett T.
AU - Resick, Patricia A.
N1 - Publisher Copyright:
© 2023 American Academy of Sleep Medicine. All rights reserved.
PY - 2023/8/1
Y1 - 2023/8/1
N2 - Study Objectives: Sleep disturbances are common in military personnel with posttraumatic stress disorder (PTSD) and may persist following treatment. This study examined service members seeking treatment for PTSD, reporting insomnia symptoms, nightmares, excessive daytime sleepiness, and potential obstructive sleep apnea at baseline and the impact of sleep disturbances on a course of PTSD treatment. Methods: In this secondary analysis, sleep was evaluated in 223 service members who participated in a randomized clinical trial comparing Cognitive Processing Therapy for PTSD delivered in individual or group formats. Sleep assessments included the Insomnia Severity Index, the Trauma-Related Nightmare Survey, and Epworth Sleepiness Scale administered at baseline and 2 weeks posttreatment. Results: Following PTSD treatment, there were significant improvements for insomnia symptoms (MD = 21.49; d = 20.27), nightmares (MD = 20.35; d = 20.27), and excessive daytime sleepiness (MD = 20.91; d = 20.16). However, mean scores remained in clinical ranges at posttreatment. Participants with baseline insomnia symptoms had worse PTSD severity throughout treatment. Participants with baseline excessive daytime sleepiness or probable obstructive sleep apnea had greater PTSD severity reductions when treated with Cognitive Processing Therapy individually vs. in a group. Those with insomnia symptoms, nightmare disorder, and sleep apnea had greater depressive symptoms throughout treatment. Conclusions: Insomnia symptoms, nightmares, and excessive daytime sleepiness were high at baseline in service members seeking treatment for PTSD. While sleep symptoms improved with PTSD treatment, these sleep disorders were related to worse treatment outcomes with regards to symptoms of PTSD and depression. Individual Cognitive Processing Therapy is recommended over group Cognitive Processing Therapy for patients with either excessive daytime sleepiness or probable obstructive sleep apnea. Clinical Trial Registration: Registry: ClinicalTrials.gov; Name: Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD; URL: https://clinicaltrials.gov/ct2/show/NCT02173561; Identifier: NCT02173561.
AB - Study Objectives: Sleep disturbances are common in military personnel with posttraumatic stress disorder (PTSD) and may persist following treatment. This study examined service members seeking treatment for PTSD, reporting insomnia symptoms, nightmares, excessive daytime sleepiness, and potential obstructive sleep apnea at baseline and the impact of sleep disturbances on a course of PTSD treatment. Methods: In this secondary analysis, sleep was evaluated in 223 service members who participated in a randomized clinical trial comparing Cognitive Processing Therapy for PTSD delivered in individual or group formats. Sleep assessments included the Insomnia Severity Index, the Trauma-Related Nightmare Survey, and Epworth Sleepiness Scale administered at baseline and 2 weeks posttreatment. Results: Following PTSD treatment, there were significant improvements for insomnia symptoms (MD = 21.49; d = 20.27), nightmares (MD = 20.35; d = 20.27), and excessive daytime sleepiness (MD = 20.91; d = 20.16). However, mean scores remained in clinical ranges at posttreatment. Participants with baseline insomnia symptoms had worse PTSD severity throughout treatment. Participants with baseline excessive daytime sleepiness or probable obstructive sleep apnea had greater PTSD severity reductions when treated with Cognitive Processing Therapy individually vs. in a group. Those with insomnia symptoms, nightmare disorder, and sleep apnea had greater depressive symptoms throughout treatment. Conclusions: Insomnia symptoms, nightmares, and excessive daytime sleepiness were high at baseline in service members seeking treatment for PTSD. While sleep symptoms improved with PTSD treatment, these sleep disorders were related to worse treatment outcomes with regards to symptoms of PTSD and depression. Individual Cognitive Processing Therapy is recommended over group Cognitive Processing Therapy for patients with either excessive daytime sleepiness or probable obstructive sleep apnea. Clinical Trial Registration: Registry: ClinicalTrials.gov; Name: Group vs. Individual Cognitive Processing Therapy for Combat-related PTSD; URL: https://clinicaltrials.gov/ct2/show/NCT02173561; Identifier: NCT02173561.
KW - cognitive processing therapy
KW - insomnia
KW - military
KW - nightmares
KW - posttraumatic stress disorder
UR - http://www.scopus.com/inward/record.url?scp=85173512876&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85173512876&partnerID=8YFLogxK
U2 - 10.5664/jcsm.10584
DO - 10.5664/jcsm.10584
M3 - Article
C2 - 36988304
AN - SCOPUS:85173512876
SN - 1550-9389
VL - 19
SP - 1389
EP - 1398
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 8
ER -